EUVIMEDEUVIMED entdecken
Crossref

SA23 DIVERSITY IN CLINICAL TRIALS: A REVIEW OF DRUGS APPROVED BY THE FDA IN 2024

Sophia Cassim, Abigail Wright, Foluso O. Agboola

Value in Health · 2026-06 · 29 (6) · S443

DOI: 10.1016/j.jval.2026.03.2191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Sophia Cassim und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Cassim, S., Wright, A., & Agboola, F. O. (2026). SA23 DIVERSITY IN CLINICAL TRIALS: A REVIEW OF DRUGS APPROVED BY THE FDA IN 2024. Value in Health, 29(6), S443. https://doi.org/10.1016/j.jval.2026.03.2191

Vancouver

Cassim S, Wright A, Agboola FO. SA23 DIVERSITY IN CLINICAL TRIALS: A REVIEW OF DRUGS APPROVED BY THE FDA IN 2024. Value in Health. 2026;29(6):S443. doi:10.1016/j.jval.2026.03.2191

BibTeX
@article{Cassim2026,
  author = {Cassim, Sophia and Wright, Abigail and Agboola, Foluso O.},
  title = {SA23 DIVERSITY IN CLINICAL TRIALS: A REVIEW OF DRUGS APPROVED BY THE FDA IN 2024},
  journal = {Value in Health},
  year = {2026},
  volume = {29},
  number = {6},
  pages = {S443},
  doi = {10.1016/j.jval.2026.03.2191}
}
Kostenlos starten →